CBS and polyarteritis nodosa: Our results with the CBS inhibitor hypericin and the CSE inhibitor APG in an in vitro PAN model show similar effects, reducing endogenous H2S production, which mediates further reductions in CD2AP and nephrin expression and promotes further oxidative stress.